taro pharma shareholders have filed suit. taro pharma merger price offered by SUn is very eggregiosly low. this merger even if voted by minority will go through long litigation and extensive damages are likely here. more can be found in "stocks dd blog" (just search that in yahoo)
Taro board accepted shameful offer of $39.5 from SUN, while comparing to DUSA offer it should be above $150, using the same metrics.
No minority shareholder would vote foe for the merger, that is why Taro delayed voting w/o date and SP is trading 14-18% above approved merger.